Your browser doesn't support javascript.
loading
Effect of sodium glucose cotransporter 2 inhibitors on atrial tachy-arrhythmia burden in patients with cardiac implantable electronic devices.
Younis, Arwa; Arous, Tania; Klempfner, Robert; Kharsa, Adnan; McNitt, Scott; Schleede, Susan; Polonski, Bronislava; Abdallah, Zeinab; Buttar, Ruppinder; Bodurian, Christopher; Tabaja, Chadi; Yavin, Hagai D; Shamroz, Farooq; Wazni, Oussama M; Wittlin, Steven D; Aktas, Mehmet; Goldenberg, Ilan.
Afiliação
  • Younis A; Department of Medicine, Division of Cardiology, Clinical Cardiovascular Research Center, University of Rochester Medical Center, Rochester, New York, USA.
  • Arous T; Department of Cardiology, Clinical Electrophysiology, Cleveland Clinic, Cleveland, Ohio, USA.
  • Klempfner R; Department of Medicine, Division of Endocrine-Metabolism, University of Rochester Medical Center, Rochester, New York, USA.
  • Kharsa A; Leviev Heart Center, Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • McNitt S; Department of Internal Medicine, Rochester General Hospital, Rochester, New York, USA.
  • Schleede S; Department of Medicine, Division of Cardiology, Clinical Cardiovascular Research Center, University of Rochester Medical Center, Rochester, New York, USA.
  • Polonski B; Department of Medicine, Division of Cardiology, Clinical Cardiovascular Research Center, University of Rochester Medical Center, Rochester, New York, USA.
  • Abdallah Z; Department of Medicine, Division of Cardiology, Clinical Cardiovascular Research Center, University of Rochester Medical Center, Rochester, New York, USA.
  • Buttar R; Department of Medicine, Division of Cardiology, Clinical Cardiovascular Research Center, University of Rochester Medical Center, Rochester, New York, USA.
  • Bodurian C; Department of Internal Medicine, Rochester General Hospital, Rochester, New York, USA.
  • Tabaja C; Department of Medicine, Division of Cardiology, Clinical Cardiovascular Research Center, University of Rochester Medical Center, Rochester, New York, USA.
  • Yavin HD; Department of Cardiology, Clinical Electrophysiology, Cleveland Clinic, Cleveland, Ohio, USA.
  • Shamroz F; Department of Cardiology, Clinical Electrophysiology, Cleveland Clinic, Cleveland, Ohio, USA.
  • Wazni OM; Department of Medicine, Division of Cardiology, Clinical Cardiovascular Research Center, University of Rochester Medical Center, Rochester, New York, USA.
  • Wittlin SD; Department of Cardiology, Clinical Electrophysiology, Cleveland Clinic, Cleveland, Ohio, USA.
  • Aktas M; Department of Medicine, Division of Endocrine-Metabolism, University of Rochester Medical Center, Rochester, New York, USA.
  • Goldenberg I; Department of Medicine, Division of Cardiology, Clinical Cardiovascular Research Center, University of Rochester Medical Center, Rochester, New York, USA.
J Cardiovasc Electrophysiol ; 34(8): 1595-1604, 2023 08.
Article em En | MEDLINE | ID: mdl-37453072
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Insuficiência Cardíaca Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Insuficiência Cardíaca Idioma: En Ano de publicação: 2023 Tipo de documento: Article